Assessment of No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years old.
• Both sexes.
• Patients with STEMI. ST-segment elevated myocardial infarction is defined as typical chest pain \>30 minutes with ST-segment elevation of \>1 mm in at least 2 consecutive leads on the electrocardiogram or new-onset left bundle brunch block.
Locations
Other Locations
Egypt
Kafrelsheikh University
RECRUITING
Kafr Ash Shaykh
Contact Information
Primary
Mohammed A Hammad, MD
drhammad879@gmail.com
00201015928694
Time Frame
Start Date: 2025-05-12
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 60
Treatments
Experimental: Intracoronary tirofiban group
Patients will receive intracoronary tirofiban (Aggrastat®) (25 mg/kg)
Placebo_comparator: Control group
Patients will receive intracoronary saline 0.9% solution as a control group.
Related Therapeutic Areas
Sponsors
Leads: Kafrelsheikh University